Amgen's $27.8 Billion Deal for Horizon Therapeutics Clears Key Hurdle – The Wall Street Journal
Business News
- Amgen’s $27.8 Billion Deal for Horizon Therapeutics Clears Key Hurdle The Wall Street Journal
- FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics acquisition CNBC
- FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics deal CNBC Television
- FTC reaches deal, drops lawsuit to block Amgen-Horizon pharma merger The Washington Post
- Amgen gets FTC’s go-ahead for $27.8 billion Horizon deal Reuters
- View Full Coverage on Google News
Source: Business News